Javed H, Nagoor Meeran M, Jha N, Ashraf G, Ojha S
Curr Top Med Chem. 2023; 24(9):797-809.
PMID: 38141184
DOI: 10.2174/0115680266273944231213070916.
Dietrich P, Alli S, Mulligan M, Cox R, Ashbrook D, Williams R
Neurobiol Dis. 2021; 162:105581.
PMID: 34871739
PMC: 8717869.
DOI: 10.1016/j.nbd.2021.105581.
Vishwas S, Gulati M, Kapoor B, Gupta S, Singh S, Awasthi A
Curr Neuropharmacol. 2020; 19(7):957-989.
PMID: 33167841
PMC: 8686322.
DOI: 10.2174/1570159X18666201109090824.
Zhang Y, Zhang M, Zhu W, Yu J, Wang Q, Zhang J
Redox Biol. 2019; 28:101365.
PMID: 31707354
PMC: 6854095.
DOI: 10.1016/j.redox.2019.101365.
Essa M, Moghadas M, Ba-Omar T, Qoronfleh M, Guillemin G, Manivasagam T
Neurotox Res. 2019; 35(3):739-774.
PMID: 30632085
DOI: 10.1007/s12640-018-9989-9.
Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease.
El-Abhar H, Abd El Fattah M, Wadie W, El-Tanbouly D
PLoS One. 2018; 13(9):e0203837.
PMID: 30260985
PMC: 6160003.
DOI: 10.1371/journal.pone.0203837.
Comparison of the Toxic Effects of Quinolinic Acid and 3-Nitropropionic Acid in C. elegans: Involvement of the SKN-1 Pathway.
Kotlar I, Colonnello A, Aguilera-Gonzalez M, Avila D, de Lima M, Garcia-Contreras R
Neurotox Res. 2017; 33(2):259-267.
PMID: 28822104
DOI: 10.1007/s12640-017-9794-x.
Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
Suganya S, Sumathi T
Metab Brain Dis. 2016; 32(2):471-481.
PMID: 27928694
DOI: 10.1007/s11011-016-9929-4.
Animal models of multiple system atrophy.
Stefanova N, Wenning G
Clin Auton Res. 2015; 25(1):9-17.
PMID: 25585910
PMC: 4412689.
DOI: 10.1007/s10286-014-0266-6.
Plants and phytochemicals for Huntington's disease.
Choudhary S, Kumar P, Malik J
Pharmacogn Rev. 2013; 7(14):81-91.
PMID: 24347915
PMC: 3841999.
DOI: 10.4103/0973-7847.120505.
Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease.
Sandhir R, Yadav A, Mehrotra A, Sunkaria A, Singh A, Sharma S
Neuromolecular Med. 2013; 16(1):106-18.
PMID: 24008671
DOI: 10.1007/s12017-013-8261-y.
Mitochondria toxin-induced acute cochlear cell death indicates cellular activity-correlated energy consumption.
Zou J, Zhang Y, Zhang W, Poe D, Zhai S, Yang S
Eur Arch Otorhinolaryngol. 2012; 270(9):2403-15.
PMID: 23179932
DOI: 10.1007/s00405-012-2267-1.
DYT1 knock-in mice are not sensitized against mitochondrial complex-II inhibition.
Bode N, Massey C, Gonzalez-Alegre P
PLoS One. 2012; 7(8):e42644.
PMID: 22880064
PMC: 3411799.
DOI: 10.1371/journal.pone.0042644.
Involvement of the up-regulated FoxO1 expression in follicular granulosa cell apoptosis induced by oxidative stress.
Shen M, Lin F, Zhang J, Tang Y, Chen W, Liu H
J Biol Chem. 2012; 287(31):25727-40.
PMID: 22669940
PMC: 3406661.
DOI: 10.1074/jbc.M112.349902.
Acute and long-term response of dopamine nigrostriatal synapses to a single, low-dose episode of 3-nitropropionic acid-mediated chemical hypoxia.
Crawford C, Akopian G, Ring J, Jakowec M, Petzinger G, Andersen J
Synapse. 2010; 65(4):339-50.
PMID: 20730800
PMC: 3032029.
DOI: 10.1002/syn.20852.
Mitochondrial matters of the brain: the role in Huntington's disease.
Turner C, Schapira A
J Bioenerg Biomembr. 2010; 42(3):193-8.
PMID: 20480217
DOI: 10.1007/s10863-010-9290-y.
Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors.
Kim D, Vallejo J, Rho J
J Neurochem. 2010; 114(1):130-41.
PMID: 20374433
PMC: 3532617.
DOI: 10.1111/j.1471-4159.2010.06728.x.
3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future.
Tunez I, Tasset I, Perez-De la Cruz V, Santamaria A
Molecules. 2010; 15(2):878-916.
PMID: 20335954
PMC: 6263191.
DOI: 10.3390/molecules15020878.
Antioxidant strategy to rescue synaptosomes from oxidative damage and energy failure in neurotoxic models in rats: protective role of S-allylcysteine.
Elinos-Calderon D, Robledo-Arratia Y, Perez-De la Cruz V, Maldonado P, Galvan-Arzate S, Pedraza-Chaverri J
J Neural Transm (Vienna). 2009; 117(1):35-44.
PMID: 19866339
DOI: 10.1007/s00702-009-0299-5.
Early nerve ending rescue from oxidative damage and energy failure by L: -carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities.
Elinos-Calderon D, Robledo-Arratia Y, Perez-De la Cruz V, Pedraza-Chaverri J, Ali S, Santamaria A
Exp Brain Res. 2009; 197(3):287-96.
PMID: 19565224
DOI: 10.1007/s00221-009-1913-3.